Literature DB >> 27665485

Predictors of sentinel lymph node metastases in breast cancer-radioactivity and Ki-67.

Fabinshy Thangarajah1, Wolfram Malter2, Stefanie Hamacher3, Matthias Schmidt4, Stefan Krämer5, Peter Mallmann6, Verena Kirn6.   

Abstract

OBJECTIVES: Since the introduction of the sentinel node technique for breast cancer in the 1990s patient's morbidity was reduced. Tracer uptake is known to be dependent from lymph node integrity and activity of macrophages. The aim of this study was to assess whether radioactivity of the tracer can predict sentinel lymph node metastases. Furthermore, a potential association with Ki-67 index was examined. Non-invasive prediction of lymph node metastases could lead to a further decrease of morbidity.
METHODS: We retrospectively analyzed patients with primary breast cancer who underwent surgery at the Department of Obstetrics and Gynecology in the University Hospital of Cologne between 2012 and 2013. Injection of radioactive tracer was done a day before surgery in the department of Nuclear Medicine. Clinical data and radioactivity of the sentinel node measured the day before and intraoperatively were abstracted from patient's files.
RESULTS: Of 246 patients, 64 patients had at least one, five patients had two and one patient had three positive sentinel lymph nodes. Occurrence of sentinel lymph node metastases was not associated with preoperative tracer activity (p = 0,319), intraoperative tracer activity of first sentinel node (p = 0,086) or with loss of tracer activity until operation (p = 0,909). There was no correlation between preoperative Ki-67 index and occurrence of lymph node metastases (p = 0,403).
CONCLUSION: In our cohort, there was no correlation between radioactivity and sentinel node metastases. Tracer uptake might not only be influenced by lymph node metastases and does not predict metastatic lymph node involvement.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ki-67 index; Lymph node metastases; Predictive factors; Radioactivity; Sentinel node biopsy

Mesh:

Substances:

Year:  2016        PMID: 27665485     DOI: 10.1016/j.breast.2016.09.003

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  4 in total

1.  Toward Exempting from Sentinel Lymph Node Biopsy in T1 Breast Cancer Patients: A Retrospective Study.

Authors:  Guozheng Li; Jiyun Zhao; Xingda Zhang; Xin Ma; Hui Li; Yihai Chen; Lei Zhang; Xin Zhang; Jiale Wu; Xinheng Wang; Yan Zhang; Shouping Xu
Journal:  Front Surg       Date:  2022-06-28

2.  Axillary nodal involvement by primary tumor features in early breast cancer: an analysis of 2600 patients.

Authors:  M C De Santis; E La Rocca; E Meneghini; G Bregni; G Di Lorenzo; G Galli; M Di Nicola; S Folli; M Gennaro; G Pruneri; B Paolini; M G Daidone; F De Braud; G Apolone; M Sant; S Di Cosimo
Journal:  Clin Transl Oncol       Date:  2019-08-01       Impact factor: 3.405

3.  Comment on 'Renewed interest in the progesterone receptor in breast cancer'.

Authors:  Giovanni Simone; Sergio Diotaiuti; Maria Digennaro; Domenico Sambiasi; Simona De Summa; Stefania Tommasi; Rosanna Altieri; Annita Mangia; Caterina Dantona; Angelo Paradiso
Journal:  Br J Cancer       Date:  2017-04-11       Impact factor: 7.640

4.  Differentiating the lymph node metastasis of breast cancer through dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Xu Dong; Yu Chunrong; Hou Hongjun; Zhang Xuexi
Journal:  BJR Open       Date:  2019-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.